ROYAL BANK OF CANADA - KEMPHARM INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$39,000
+18.2%
7,900
+20.6%
0.00%
Q2 2023$33,000
+371.4%
6,552
+452.0%
0.00%
Q1 2023$7,000
-75.9%
1,187
-80.6%
0.00%
Q4 2022$29,000
+11.5%
6,122
+44.7%
0.00%
Q3 2022$26,000
-3.7%
4,230
-31.6%
0.00%
Q2 2022$27,000
-50.9%
6,184
-43.2%
0.00%
Q1 2022$55,000
-58.3%
10,879
-28.0%
0.00%
Q4 2021$132,000
+53.5%
15,114
+62.3%
0.00%
Q3 2021$86,000
-12.2%
9,313
+22.1%
0.00%
Q2 2021$98,000
+84.9%
7,626
+32.7%
0.00%
Q1 2021$53,0005,7480.00%
Other shareholders
KEMPHARM INC shareholders Q4 2023
NameSharesValueWeighting ↓
Nantahala Capital Management 2,308,216$11,125,6010.95%
Retirement Planning Co of New England, Inc. 347,402$1,674,4780.93%
Mystic Asset Management, Inc. 203,283$979,8240.55%
Kovack Advisors, Inc. 124,109$598,2080.08%
Arete Wealth Advisors, LLC 80,729$389,1140.07%
City State Bank 14,224$690.04%
IFG Advisors, LLC 12,900$62,1780.02%
Measured Wealth Private Client Group, LLC 10,000$48,2000.02%
VisionPoint Advisory Group, LLC 6,860$33,0650.01%
OCCUDO QUANTITATIVE STRATEGIES LP 22,615$109,0040.01%
View complete list of KEMPHARM INC shareholders